OUR COMPANY

Clinical laboratory tests save costs and lives by enabling early detection and prevention of disease.

Patients with cancers and other conditions are living longer and enjoying better health because of medical revolutions in diagnostic technology.

At its center are genetic and genomic tests that identify the unique genetic profile of individual patients or their disease and allow physicians to tailor treatment to those unique characteristics.

Mainz BioMed (NASDAQ: MYNZ) develops market-ready molecular genetic diagnostic solutions for life-threatening conditions.

Mainz, Germany

Mainz Biomed (NASDAQ: MYNZ) is located just west of Frankfurt in a world-renowned community for advanced DNA & Pharmaceutical research, including the home of vaccine maker BioNTech SE.

The TÜV Rheinland certifies that Mainz Biomed manufactures ColoAlert according to DIN EN ISO 13485. Click here to view certificate.

Mainz Biomed has historical research & development collaborations with major universities, laboratories and governments across Europe.

LEAD PRODUCT

ColoAlert detects tumors better than the standard test (FIT)*

Approved for sale in EU

*Dollinger MM et al. (2018), ClinLab 64 (10), 1719-1730; internal data comparing ColoAlert to FIT. NOTE: the globally most-used non-invasive test for screening programs.  Fecal immunochemical test (FIT) is a screening test for  hidden blood in the stool, which can be an early sign of cancer. FIT only detects human blood from the lower intestines. Blood in stool is often a late-stage sign.

** As defined in ColoAlert instructions for use.

1 Colorectal cancer is the second leading cause of cancer death in the US – Cancer.org

2 5-Year Survival rate 91% at Stage A – 2018 American Cancer Society Report

3 Predicted deaths from CRC in USA – Cancer.org.

MANAGEMENT TEAM

GUIDO
BAECHLER

CEO & DIRECTOR

WILLIAM
CARAGOL

CFO

MORITZ
EIDENS​ PhD

CSO & DIRECTOR

PHILIPP
FREESE ​

CBO

DARIN
LEIGH

CHIEF COMMERCIAL OFFICER

JANE
EDWARDS

VP of Clinical Affairs

DR. CHRIS
VON TÖRNE, PhD

COO

DR. FRANK
KRIEG-SCHNEIDER

CTO

STEFAN
ERLACH

HEAD OF HUMAN RESOURCES

BOARD OF DIRECTORS & ADVISORS

DR. HEINER
DREISMANN

Chairman & Non Executive Director

NICOLE
HOLDEN

DIRECTOR

HANS
HEKLAND

DIRECTOR

MORITZ
EIDENS​ PhD

DIRECTOR & CSO

GUIDO
BAECHLER

DIRECTOR & CEO

ALBERTO
LIBANORI

DIRECTOR

Dr. Soren
Thestrup-Nielsen M.D.

CLINICAL ADVISOR

Dr. Michele
Pedrocchi

ADVISOR

Dr. Rainer
Metzger

ADVISOR

KAREN L.
RICHARDS

ADVISOR

GREGORY
TIBBITTS

Director